AP AQUINOX PHARMACEUTICALS, INC Stock: price and management transactions · United States · SEC (Form 4)Follow the AQUINOX PHARMACEUTICALS, INC stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 26 January 2016 (Acquisition). Among the most active insiders: BAKER BROS. ADVISORS LP. All data is openly available.
Analyst consensus: bullish or bearish? Analysts rate AQUINOX PHARMACEUTICALS, INC Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 26 January 2016
All Executives60 Thresholds0 Prospectus0 Other0
Declarations 60 total
▲ 10% Owner · Executives · 22 Jan 2016
1,887 shares Common Stock SEC:0001144204-16-077069:0
Canonical exit: 21 Apr 2016 (T+90) ▲ 10% Owner · Executives · 22 Jan 2016
17,221 shares Common Stock SEC:0001144204-16-077069:1
Canonical exit: 21 Apr 2016 (T+90) ▲ 10% Owner · Executives · 22 Jan 2016
440 shares Common Stock SEC:0001144204-16-077069:2
Canonical exit: 21 Apr 2016 (T+90) ▲ 10% Owner · Executives · 22 Jan 2016
4,021 shares Common Stock SEC:0001144204-16-077069:3
Canonical exit: 21 Apr 2016 (T+90) ▲ 10% Owner · Executives · 22 Jan 2016
17 shares Common Stock SEC:0001144204-16-077069:4
Canonical exit: 21 Apr 2016 (T+90) ▲ 10% Owner · Executives · 22 Jan 2016
156 shares Common Stock SEC:0001144204-16-077069:5
Canonical exit: 21 Apr 2016 (T+90) ▲ 10% Owner · Executives · 22 Jan 2016
2,810 shares Common Stock SEC:0001144204-16-077069:6
Canonical exit: 21 Apr 2016 (T+90) ▲ 10% Owner · Executives · 22 Jan 2016
25,650 shares Common Stock SEC:0001144204-16-077069:7
Canonical exit: 21 Apr 2016 (T+90) ▲ 10% Owner · Executives · 25 Jan 2016
312 shares Common Stock SEC:0001144204-16-077069:8
Canonical exit: 24 Apr 2016 (T+90) ▲ 10% Owner · Executives · 25 Jan 2016
2,833 shares Common Stock SEC:0001144204-16-077069:9
Canonical exit: 24 Apr 2016 (T+90) ▲ 10% Owner · Executives · 25 Jan 2016
497 shares Common Stock SEC:0001144204-16-077069:10
Canonical exit: 24 Apr 2016 (T+90) ▲ 10% Owner · Executives · 25 Jan 2016
4,503 shares Common Stock SEC:0001144204-16-077069:11
Canonical exit: 24 Apr 2016 (T+90) ▲ 10% Owner · Executives · 25 Jan 2016
278 shares Common Stock SEC:0001144204-16-077069:12
Canonical exit: 24 Apr 2016 (T+90) ▲ 10% Owner · Executives · 25 Jan 2016
2,522 shares Common Stock SEC:0001144204-16-077069:13
Canonical exit: 24 Apr 2016 (T+90) ▲ 10% Owner · Executives · 26 Jan 2016
7,318 shares Common Stock SEC:0001144204-16-077069:14
Canonical exit: 25 Apr 2016 (T+90) ▲ 10% Owner · Executives · 26 Jan 2016
66,345 shares Common Stock SEC:0001144204-16-077069:15
Canonical exit: 25 Apr 2016 (T+90) ▲ 10% Owner · Executives · 26 Jan 2016
395 shares Common Stock SEC:0001144204-16-077069:16
Canonical exit: 25 Apr 2016 (T+90) ▲ 10% Owner · Executives · 26 Jan 2016
3,581 shares Common Stock SEC:0001144204-16-077069:17
Canonical exit: 25 Apr 2016 (T+90) ▲ 10% Owner · Executives · 19 Jan 2016
5,029 shares Common Stock SEC:0001144204-16-076372:0
Canonical exit: 18 Apr 2016 (T+90) ▲ 10% Owner · Executives · 19 Jan 2016
45,903 shares Common Stock SEC:0001144204-16-076372:1
Canonical exit: 18 Apr 2016 (T+90) ▲ 10% Owner · Executives · 19 Jan 2016
1,109 shares Common Stock SEC:0001144204-16-076372:2
Canonical exit: 18 Apr 2016 (T+90) ▲ 10% Owner · Executives · 19 Jan 2016
10,123 shares Common Stock SEC:0001144204-16-076372:3
Canonical exit: 18 Apr 2016 (T+90) ▲ 10% Owner · Executives · 19 Jan 2016
1,568 shares Common Stock SEC:0001144204-16-076372:4
Canonical exit: 18 Apr 2016 (T+90) ▲ 10% Owner · Executives · 19 Jan 2016
14,313 shares Common Stock SEC:0001144204-16-076372:5
Canonical exit: 18 Apr 2016 (T+90) ▲ 10% Owner · Executives · 20 Jan 2016
6,294 shares Common Stock SEC:0001144204-16-076372:6
Canonical exit: 19 Apr 2016 (T+90) 25 of 60 declarations
Load more (35 remaining) About AQUINOX PHARMACEUTICALS, INC AQUINOX PHARMACEUTICALS, INC is a company focused on developing innovative treatments for cancer. It is listed on NASDAQ under the symbol XNAS.